rs3743074

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000743.5(CHRNA3):​c.268-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 1,587,198 control chromosomes in the GnomAD database, including 316,958 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.62 ( 29885 hom., cov: 32)
Exomes 𝑓: 0.63 ( 287073 hom. )

Consequence

CHRNA3
NM_000743.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0001611
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0270

Publications

41 publications found
Variant links:
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
  • urinary bladder, atony of
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 15-78617138-G-A is Benign according to our data. Variant chr15-78617138-G-A is described in ClinVar as Benign. ClinVar VariationId is 1209768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA3NM_000743.5 linkc.268-5C>T splice_region_variant, intron_variant Intron 3 of 5 ENST00000326828.6 NP_000734.2
CHRNA3NM_001166694.2 linkc.268-5C>T splice_region_variant, intron_variant Intron 3 of 5 NP_001160166.1
CHRNA3NR_046313.2 linkn.470-5C>T splice_region_variant, intron_variant Intron 3 of 7
CHRNA3XM_006720382.4 linkc.67-5C>T splice_region_variant, intron_variant Intron 3 of 5 XP_006720445.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA3ENST00000326828.6 linkc.268-5C>T splice_region_variant, intron_variant Intron 3 of 5 1 NM_000743.5 ENSP00000315602.5
CHRNA3ENST00000348639.7 linkc.268-5C>T splice_region_variant, intron_variant Intron 3 of 5 1 ENSP00000267951.4
CHRNA3ENST00000559658.5 linkn.268-5C>T splice_region_variant, intron_variant Intron 3 of 7 2 ENSP00000452896.1

Frequencies

GnomAD3 genomes
AF:
0.623
AC:
94691
AN:
151890
Hom.:
29847
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.561
Gnomad AMI
AF:
0.595
Gnomad AMR
AF:
0.751
Gnomad ASJ
AF:
0.637
Gnomad EAS
AF:
0.562
Gnomad SAS
AF:
0.674
Gnomad FIN
AF:
0.651
Gnomad MID
AF:
0.790
Gnomad NFE
AF:
0.628
Gnomad OTH
AF:
0.651
GnomAD2 exomes
AF:
0.660
AC:
163858
AN:
248206
AF XY:
0.659
show subpopulations
Gnomad AFR exome
AF:
0.565
Gnomad AMR exome
AF:
0.837
Gnomad ASJ exome
AF:
0.655
Gnomad EAS exome
AF:
0.562
Gnomad FIN exome
AF:
0.660
Gnomad NFE exome
AF:
0.627
Gnomad OTH exome
AF:
0.659
GnomAD4 exome
AF:
0.630
AC:
904076
AN:
1435190
Hom.:
287073
Cov.:
26
AF XY:
0.631
AC XY:
451579
AN XY:
715342
show subpopulations
African (AFR)
AF:
0.567
AC:
18687
AN:
32958
American (AMR)
AF:
0.827
AC:
36709
AN:
44380
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
16625
AN:
25918
East Asian (EAS)
AF:
0.577
AC:
22813
AN:
39566
South Asian (SAS)
AF:
0.686
AC:
58588
AN:
85412
European-Finnish (FIN)
AF:
0.655
AC:
34669
AN:
52950
Middle Eastern (MID)
AF:
0.724
AC:
4135
AN:
5710
European-Non Finnish (NFE)
AF:
0.619
AC:
674388
AN:
1088806
Other (OTH)
AF:
0.630
AC:
37462
AN:
59490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14286
28572
42858
57144
71430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17958
35916
53874
71832
89790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.624
AC:
94777
AN:
152008
Hom.:
29885
Cov.:
32
AF XY:
0.625
AC XY:
46447
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.561
AC:
23237
AN:
41446
American (AMR)
AF:
0.751
AC:
11481
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.637
AC:
2209
AN:
3468
East Asian (EAS)
AF:
0.562
AC:
2897
AN:
5156
South Asian (SAS)
AF:
0.676
AC:
3263
AN:
4828
European-Finnish (FIN)
AF:
0.651
AC:
6869
AN:
10558
Middle Eastern (MID)
AF:
0.777
AC:
227
AN:
292
European-Non Finnish (NFE)
AF:
0.628
AC:
42670
AN:
67962
Other (OTH)
AF:
0.656
AC:
1384
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1838
3676
5515
7353
9191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.630
Hom.:
72101
Bravo
AF:
0.627
Asia WGS
AF:
0.641
AC:
2230
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Urinary bladder, atony of Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.9
DANN
Benign
0.54
PhyloP100
-0.027
Mutation Taster
=53/47
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00016
dbscSNV1_RF
Benign
0.052
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3743074; hg19: chr15-78909480; COSMIC: COSV58776490; COSMIC: COSV58776490; API